APA Alıntı

Molenaar, R. J., Radivoyevitch, T., Nagata, Y., Khurshed, M., Przychodzen, B., Makishima, H., . . . Maciejewski, J. P. (2018). IDH1/2 mutations sensitize acute myeloid leukemia to PARP inhibition and this is reversed by IDH1/2-mutant inhibitors. Clin Cancer Res.

Chicago Stili Alıntı

Molenaar, Remco J., et al. "IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed By IDH1/2-mutant Inhibitors." Clin Cancer Res 2018.

MLA Alıntı

Molenaar, Remco J., et al. "IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed By IDH1/2-mutant Inhibitors." Clin Cancer Res 2018.